Search

Your search keyword '"Stephen Hamilton-Dutoit"' showing total 97 results

Search Constraints

Start Over You searched for: Author "Stephen Hamilton-Dutoit" Remove constraint Author: "Stephen Hamilton-Dutoit" Topic oncology Remove constraint Topic: oncology
97 results on '"Stephen Hamilton-Dutoit"'

Search Results

1. Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark

2. The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer

3. PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study

4. Abstract P5-03-11: The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer

5. Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients

6. CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

7. Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients

8. Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling

9. Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study

10. Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia

11. Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in Denmark

12. High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma

13. Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma

14. Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder

15. PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation

16. Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin

17. Glycolytic biomarkers predict transformation in patients with follicular lymphoma

18. Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients

19. 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence:a Danish population-based study

20. High intratumoural galectin-1 expression predicts adverse outcome in ALK− ALCL and CD30+ PTCL-NOS

21. Myeloproliferative and lymphoproliferative malignancies occurring in the same patient:A nationwide discovery cohort

22. Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

23. DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study

24. Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity

25. Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence:a Danish population-based nested case-control study

26. Expression of survivin does not appear to influence breast cancer recurrence risk

27. Abstract P3-07-23: CYP2D6 genotype and breast cancer recurrence in tamoxifen treated patients: An evaluation of the importance of loss-of-heterozygosity

28. Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma

29. 1249P PD-L1 expression and survival in stage III unresectable non-small cell lung cancer patients in Denmark

30. MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma

31. Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders

32. Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence

33. Quantification of microRNA-21 and microRNA-125b in melanoma tissue

34. Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study

35. SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations

36. Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry

37. The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study

38. Advanced Hepatocellular Carcinoma in Adolescence Associated with Congenital Cholestasis: A Case Description

39. An interim assessment of key biomarkers (programmed cell death receptor ligand 1 (PD-L1) expression and epidermal growth factor receptor (EGFR) in third-line therapy non-small cell lung cancer (NSCLC) patients:A Danish cohort study

40. Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study

41. BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping

42. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study

43. P2.01-043 PD-L1 Expression, EGFR and KRAS Mutations in First-Line Therapy (1L) for Non-Small Cell Lung Cancer (NSCLC) Patients

45. Tumor and inflammation markers in melanoma using tissue microarrays

46. Functional Polymorphisms in UDP-Glucuronosyl Transferases and Recurrence in Tamoxifen-Treated Breast Cancer Survivors

47. Differential protein expression of peroxiredoxin-1 in classical Hodgkin Lymphoma: a possible correlation to clinical behaviour

48. Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark

49. The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK, DUSP22 and TP63 Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis

50. EBV-associated gastric carcinoma in high- and low-incidence areas for nasopharyngeal carcinoma

Catalog

Books, media, physical & digital resources